Cargando…
N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry
BACKGROUND: Axonal degeneration is considered to play a major role in the development of clinical disability in multiple sclerosis (MS). N-AcetylAspartic Acid (NAA) is a neuron-specific marker constantly identified in MR-spectroscopy studies of the normal and MS brain. To our knowledge there are no...
Autores principales: | Jasperse, Bas, Jakobs, Cornelis, Eikelenboom, M. Judith, Dijkstra, Christine D., Uitdehaag, Bernard M. J., Barkhof, Frederik, Polman, Chris H., Teunissen, Charlotte E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Steinkopff-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797839/ https://www.ncbi.nlm.nih.gov/pubmed/17415509 http://dx.doi.org/10.1007/s00415-006-0415-5 |
Ejemplares similares
-
Gas Chromatography-Mass Spectrometry-Based Metabolic Profiling of
Cerebrospinal Fluid from Epileptic Dogs
por: HASEGAWA, Tetsuya, et al.
Publicado: (2013) -
The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
por: Coerver, Eline M. E., et al.
Publicado: (2022) -
Metabolic Profiling and Quantitative Analysis of Cerebrospinal Fluid Using Gas Chromatography–Mass Spectrometry: Current Methods and Future Perspectives
por: Pautova, Alisa, et al.
Publicado: (2021) -
Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
por: Leurs, Cyra E, et al.
Publicado: (2017) -
Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach
por: Yang, Hao, et al.
Publicado: (2022)